Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 1 - General processes for the preparation of peptides
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
11/2008
11/27/2008US20080293591 Repeatable Protein Arrays
11/27/2008US20080293118 Magnetic fine particles having lower critical solution temperature
11/27/2008US20080293094 Novel Enzymatic Substrates Derived from Phenoxazinone and Their Use as Developer in Detection of Microorganisms with Peptidase Activity
11/27/2008US20080292645 Antibody or Antibody Fragment Coupled with an Immunogenic Agent
11/27/2008US20080292642 Crystalline anti-human IL-12 antibodies
11/27/2008US20080292635 Allergenic latex protein
11/27/2008US20080290034 Bridged macrocyclic module compositions
11/27/2008US20080289963 Gel for Isoelectric Focusing
11/27/2008DE10224257B4 Verfahren zur Gewinnung eines Proteinisolats und einer Faserfraktion aus einer faser- und proteinhaltigen Ausgangssubstanz A process for obtaining a protein isolate and a fiber fraction from a fibrous and proteinaceous starting substance
11/27/2008CA2686740A1 Devices and methods for reducing matrix effects
11/27/2008CA2684885A1 Preparative purification process for human furin
11/27/2008CA2684151A1 Method for producing mature vwf from vwf pro-peptide
11/27/2008CA2683288A1 Crystalline and amorphous forms of peptide
11/26/2008EP1995324A1 Cell-free protein synthesis of deuterated proteins for structural and functional studies by NMR spectroscopy
11/26/2008EP1995313A1 Novel phospholipase c
11/26/2008EP1995254A1 Method of producing peptide
11/26/2008EP1994972A1 Method and device for continuous chromatographic separations
11/26/2008EP1994941A2 Medicine containing at least one oxidised protein
11/26/2008EP1994413A2 Mass tags for quantitative analyses
11/26/2008EP1994054A2 Methods and systems for isolating target molecules from complex solutions by column-chromatography using eluants containing organic solvents
11/26/2008EP1993592A2 Compositions containing lactoferrin, and methods of using same to promote growth of skin cells
11/26/2008EP1960783A4 Reduction of non-specific binding in assays
11/26/2008EP1841783A4 Second tc complex from xenorhabdus
11/26/2008EP1276492B1 P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
11/26/2008EP1173481B1 Inactivated cytokines for immunisation
11/26/2008EP0820463B1 Igf-i purification process
11/26/2008EP0735893B1 Pan dr-binding peptides for enhancement of the immune response
11/26/2008CN101313223A Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-l-yl methylene or a pyrimidin-2-yl thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group
11/26/2008CN101312986A Method of producing a modified (poly)peptide
11/26/2008CN101311195A Method for preparing homogenization solid phase synthesis carrier microballoons
11/26/2008CN101311151A Process for the preparation of 3,3-dimethylbutanal
11/26/2008CN100436476C Method for preparing dielectrophoresis sample of whole protein of pollen tube in gymnosperm
11/25/2008US7456276 Peptide purification by means of metal ion affinity chromatography
11/25/2008US7456255 Nogo receptor homologs that decrease inhibition of axonal elongation
11/25/2008US7456011 For delivering a therapeutic protein to the mucosal surface of human vagina or gastrointestinal tract; binds to gp 120 of human immunodeficiency virus (HIV) and inhibits the infectivity of HIV
11/25/2008US7456000 Conjugate formed by reacting a first compound with a second compound (particularly biomacromolecules) in which the conjugation involves an electrophilic moiety; deactivation by reacing unreacted electrophilic moieties with a nucleophilic reagent (hydrazine or an alkylenediamine); immunoassay reagents
11/25/2008US7455982 Automated methods of detecting receptor activity
11/25/2008US7455978 Protein/solubility folding assessed by structural complementation
11/25/2008US7455155 Impact absorbent assembly in slope protection systems
11/25/2008CA2401663C Protein mapping
11/20/2008WO2008140477A2 Hybrid immunoglobulins with moving parts
11/20/2008WO2008138916A1 Isolation of peptides and proteomics platform
11/20/2008WO2008138621A2 Synthesis of aminocyclopentane carboxylic acids
11/20/2008WO2008138620A2 1-aminocyclopentane-1,3,4-tricarboxylic acids derivatives
11/20/2008WO2008106660A3 Isolated phospholipid-protein particles
11/20/2008WO2008098693A3 Convergent synthesis of glp-1
11/20/2008WO2008091740A3 Polyelectrolyte precipitation and purification of antibodies
11/20/2008WO2008064239A3 Imidazolidine derivative mass tags
11/20/2008WO2008036929A3 Complex for transferring an anionic substance into a cell
11/20/2008WO2007117490A3 Antibody purification
11/20/2008WO2007112451A3 Covalent conjugates between endoperoxides and transferrin and lactoferrin receptor-binding agents
11/20/2008WO2007075414A3 Chemically derivatized cd4 and uses thereof
11/20/2008WO2007018619A3 Chimeric therapeutic agents
11/20/2008WO2006096828A3 Chimeric proteins with phosphatidylserine binding domains
11/20/2008US20080289056 Aldolases, nucleic acids encoding them; improving thermal stability of enzyme; biosynthesis of atorvastatin, rosuvastatin, fluvastatin starting from e.g. acetaldehyde and chloroacetaldehyde, using enzyme 2-deoxyribose-5-phosphate aldolase (DERA) to form pyran intermediate
11/20/2008US20080287655 Method of producing s-nitrosoprotein preparation
11/20/2008US20080287653 Method for producing inhibitors and inhibitors formed therefrom
11/20/2008US20080287650 High purity peptides
11/20/2008US20080287635 Latex Adhesives Derived From Ionic Strength Induced Soy Protein Complexes
11/20/2008US20080287346 Bioactive peptides
11/20/2008US20080286877 Displacement assay for detection of small molecules
11/20/2008US20080286808 Methods for production of unstructured recombinant polymers and uses thereof
11/20/2008US20080286263 Diagnosis Of Neurodegenerative Diseases
11/20/2008CA2668208A1 Hybrid immunoglobulins with moving parts
11/19/2008EP1992692A1 Immunoglobulin affinity ligand
11/19/2008EP1992637A1 1-Aminocyclopentane-1,3,4- tricarboxylic acids derivatives
11/19/2008EP1992636A2 Process for correction of a disulfide misfold in Fc molecules
11/19/2008EP1992611A1 Novel isodipeptide
11/19/2008EP1992610A1 New route of synthesis
11/19/2008EP1692156A4 Self-assembling split-fluorescent protein systems
11/19/2008EP1421175B1 Polymer stabilized proteinases
11/19/2008EP1171455B1 Polypeptide-k obtained from momordica charantia and a process for the extraction thereof
11/19/2008CN101309932A Novel mucin glycoprotein and use thereof
11/19/2008CN101309928A E2EPF ubiquitin carrier protein-VON HIPPEL-LINDAU interaction and uses thereof
11/19/2008CN101307348A Method for preparing undenatured collagen from fish scale of fresh water fish
11/19/2008CN101307315A Method for expressing growth factor of human blood vessel in bombyx mori by Bac-to-Bac system
11/19/2008CN101307108A Anti-phosphorylation Tau protein antibody use for detecting AD sign abnormal phosphation Tau protein level
11/19/2008CN101307094A Novel nuclear factor ¿Ckappa B p65 subunit antagonizing polypeptide
11/19/2008CN101307093A Method for separating and purifying collagen for biopharmaceutical use from sharkskin
11/19/2008CN101307092A Method for synthesizing general artificial antigen of beta-lactam drugs
11/19/2008CN101306352A Large particle diameter mono-disperse polymer microspheres containing epoxy group and preparation method thereof
11/19/2008CN101306200A Preparation method of hepatitis b human immunoglobulin for intravenous injection
11/18/2008US7452982 An immunogenic complex characterised in that an enzyme is integrated into an immunostimulating complex (ISCOM) containing a glycoside, a lipid and an antigen
11/18/2008US7452974 Drug targets related to synthase subfamily; alternative splice forms; isolated peptides and antibodies
11/18/2008US7452972 Nucleic acids and proteins showing increased expression dose under salt stress
11/18/2008US7452969 Neurotrophic factor protein and uses thereof
11/18/2008US7452965 nine amino acid, disulfide-constrained peptide that selectively bound and was internalized into colon cancer cells; exhibit decreased or a substantially nonexistent immunogenicity in an in vivo system
11/18/2008US7452862 Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists
11/18/2008US7452544 Bacteriocins and novel bacterial strains
11/18/2008CA2360322C New hydrophobic polymer comprising fluorine moieties
11/18/2008CA2338721C New cofactors for methyltransferases
11/18/2008CA2331850C Method of preparing carboxylic acid derivatives and condensing agent comprising a quaternary ammonium salt
11/18/2008CA2313515C A process for preparing a kappa-caseino glycomacropeptide or a derivative thereof
11/18/2008CA2232673C Container for drying biological samples, method of making such container, and method of using same
11/18/2008CA2221517C Synthesis of n-substituted oligomers
11/18/2008CA2138594C Process for preparing clear sera which are stable over a long period
11/16/2008CA2681295A1 Novel methods for recovery of leaf proteins
11/13/2008WO2008137165A1 Anti-glycated cd59 antibodies and uses thereof
11/13/2008WO2008137066A1 Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases
11/13/2008WO2008135568A1 Chromatography process for obtaining a fviii/vwf complex with different ratios between the two proteins, for use in haemophilia a treatment and in von willebrand disease
1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 518